Used primarily in research and development, CDDO-2P-Imidazolide plays a significant role in studying anti-inflammatory and anti-cancer pathways. It is known to activate Nrf2, a transcription factor that regulates antioxidant proteins, which helps in protecting against oxidative damage. This makes it valuable in exploring treatments for diseases linked to oxidative stress, such as neurodegenerative disorders and certain cancers. Additionally, it is utilized in investigating its potential to modulate immune responses and inhibit tumor growth in preclinical studies. Its applications are largely confined to laboratory settings for advancing therapeutic strategies.